IL-4-dependent proliferation of BA/F3 cells expressing a growth-negative mutant of the human IL-4 receptor is restored by enforced expression of Bcl-2

被引:0
|
作者
Chung, J [1 ]
Deutsch, HHJ [1 ]
Kalthoff, FS [1 ]
机构
[1] SANDOZ GMBH,FORSCHUNGSINST,DEPT IMMUNODERMATOL,A-1235 VIENNA,AUSTRIA
关键词
apoptosis; supertransfection; growth mediation;
D O I
10.1002/jlb.59.4.586
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have studied the regulation of growth and apoptosis in murine BA/F3 cells stably expressing cytoplasmic deletion mutants of the human interleukin-4 receptor (hIL-4R). Previously, we showed that BA/F3 cell transfectants expressing a cytoplasmic deletion mutant of the hIL-4R that lacks the region between Thr(462) and Ala(580), referred to as Delta R3, fails to proliferate in the presence of hIL-4. Here we report that supertransfection of Delta RS-expressing cells with a constitutively active murine bcl-2 gene results in prolonged survival of the Delta R3/bcl-2 double transfectants in the absence of cytokines. More importantly, however, the constitutive expression of Bcl-2 restored their capacity to grow permanently with hIL-4. This may provide an explanation for the discrepancy with previous reports showing growth mediation by hIL-4R truncated at position 367.
引用
收藏
页码:586 / 590
页数:5
相关论文
共 48 条
  • [41] ESTABLISHED IL-2-DEPENDENT DOUBLE-NEGATIVE (CD4(-) CD8(-)) TCR-ALPHA-BETA/CD3(+) ATL CELLS - INDUCTION OF CD4 EXPRESSION
    YAMADA, Y
    FUJITA, M
    SUZUKI, H
    ATOGAMI, S
    SOHDA, H
    MURATA, K
    TSUKASAKI, K
    MOMITA, S
    KOHNO, T
    MAEDA, T
    JOH, T
    KAMIHIRA, S
    SHIKU, H
    TOMONAGA, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) : 234 - 241
  • [42] EFFECTS OF INTERLEUKIN-4 (IL-4), TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) AND 1,25(OH)2D3 ON DIFFERENTIATION OF HUMAN BONE-MARROW STROMAL CELLS
    OYAJOBI, BO
    LIU, P
    RUSSELL, RGG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S312 - S312
  • [43] IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells:: Synergistic effect of IL-4 and IgE on human mast cell Fcε receptor I expression and mediator release
    Yamaguchi, M
    Sayama, K
    Yano, K
    Lantz, CS
    Noben-Trauth, N
    Ra, C
    Costa, JJ
    Galli, SJ
    JOURNAL OF IMMUNOLOGY, 1999, 162 (09): : 5455 - 5465
  • [44] IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
    Zorn, Emmanuel
    Nelson, Erik A.
    Mohseni, Mehrdad
    Porcheray, Fabrice
    Kim, Haesook
    Litsa, Despina
    Bellucci, Roberto
    Raderschall, Elke
    Canning, Christine
    Soiffer, Robert J.
    Frank, David A.
    Ritz, Jerome
    BLOOD, 2006, 108 (05) : 1571 - 1579
  • [45] 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells
    Yoshizato, H
    Tanaka, M
    Fujikawa, T
    Higashimoto, Y
    Shimizu, A
    Nakashima, K
    ENDOCRINE JOURNAL, 2000, 47 : S37 - S40
  • [46] BYLieve: A phase 2 study of alpelisib with fulvestrant or letrozole for treatment of PIK3CA mutant, hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (aBC) progressing on/after cyclin-dependent kinase (CDK)4/6 inhibitor therapy
    Rugo, Hope S.
    Turner, Nicholas
    Chia, Stephen
    Ciruelos, Eva
    Nienstedt, Carolyn
    Ridolfi, Antonia
    Kong, Oliver
    Sankaran, Banu
    Juric, Dejan
    CANCER RESEARCH, 2018, 78 (04)
  • [47] BYLieve: A phase II study of alpelisib (ALP) with fulvestrant (FUL) or letrozole (LET) for treatment of PIK3CA mutant, hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (aBC) progressing on/after cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy.
    Rugo, Hope S.
    Bianchi, Giulia Valeria
    Chia, Stephen K. L.
    Turner, Nicholas C.
    Juric, Dejan
    Jacot, William
    Borrego, Manuel Ruiz
    Chap, Linnea I.
    Brown-Glaberman, Ursa Abigail
    Nienstedt, Carolyn C.
    Sophos, Nikos
    Ridolfi, Antonia
    Lin, Chinjune
    Ciruelos, Eva
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING-PROTEIN-1, FACTOR-BINDING-PROTEIN-2, FACTOR-BINDING-PROTEIN-3, FACTOR-BINDING-PROTEIN-4, FACTOR-BINDING-PROTEIN-5, AND FACTOR-BINDING-PROTEIN-6 - SYNTHESIS, SECRETION, AND GENE-EXPRESSION IN ESTROGEN RECEPTOR-NEGATIVE HUMAN BREAST-CARCINOMA CELLS
    SHEIKH, MS
    SHAO, ZM
    HUSSAIN, A
    CLEMMONS, DR
    CHEN, JC
    ROBERTS, CT
    LEROITH, D
    FONTANA, JA
    JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 155 (03) : 556 - 567